Search results
IMAX Commits to ‘Megalopolis’ Showings No Matter the Distributor
Indiewire via Yahoo News· 7 hours agoHelfand announced the company’s upcoming 2025 filmed for IMAX slate (below) while at Cannes, which...
Danny DeVito's bonkers Super Mario Bros Movie 2 Wario admission
ClutchPoints· 5 hours agoIf The Super Mario Bros Movie sequel needs a Wario, Danny DeVito is your man. In an interview with...
Q3 2024 Cisco Systems Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 9 hours agoDivision George Charles Notter; MD & Equity Research Analyst; Jefferies LLC, Research Division Ittai Kidron; MD; Oppenheimer & Co. Inc., Research Division James Edward Fish ...
Oppenheimer Fellows to Gain Broader View of Nation | Newswise
Newswise· 4 days agoNuclear physicist Douglas Higinbotham, operations director for the...
IMAX Commits to ‘Megalopolis’ Showings No Matter the Distributor
indieWIRE· 7 hours agoAt Cannes, IMAX revealed its 2025 slate while saying it would commit to showings of 'Megalopolis'...
Alibaba To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Thursday - Alibaba Gr Holding...
Benzinga· 9 hours agoSPIR from $24 to $20. Stifel analyst Erik Rasmussen maintained a Buy rating. Spire Global shares...
A Timeline of Hailey Bieber’s Best Maternity-Style Moments
Harper's Bazaar via AOL· 7 hours agoFor the event, the model chooses a steely double-breasted blazer and matching slacks, which pool...
Cellectar Biosciences stock target raised, maintains outperform on Q1 results By Investing.com
Investing.com· 2 days agoOn Tuesday, Oppenheimer showed confidence in Cellectar Biosciences shares (NASDAQ:CLRB) by raising...
Those sickened by U.S. nuclear testing program take their fight to Congress
NPR· 6 hours agoIn all, the Justice Department program has disbursed $2.7 billion in payments to more 40,000...
Immunocore (NASDAQ:IMCR) Price Target Cut to $88.00
ETF DAILY NEWS· 14 hours agoSeveral other research analysts also recently commented on IMCR. Oppenheimer restated an outperform rating and issued a $87.00 target price (up previously from $85.00) on ...
